Six high school graduates have been accepted to the College of Medicine – Tucson’s new accelerated MD program.

G. Marie Swanson, founding dean and professor emerita of the Mel and Enid Zuckerman College of Public Health, writes a letter to the editor about Gov. Doug Ducey's executive order prohibiting COVID-19 vaccine mandates and mask requirements at Arizona's public universities.

The UArizona College of Medicine – Tucson has accepted six high school graduates in a new program that reduces the time to a medical degree to seven years.

When a new exam format collided with obstacles created by the pandemic, a College of Pharmacy team found a way to help students continued to succeed.

A recent University of Arizona College of Pharmacy study suggests that Objective Structured Clinical Examinations (OSCEs) may be a valuable means of assessing clinical skills while providing pharmacy students learning experiences in community pharmacy settings.

Quitting smoking is a challenge for many Americans, but according to Dr. Alicia Allen, women in postpartum may have it the hardest. "Even though half, or maybe even 60% of pregnant women, quit smoking, almost all of them relapse within a year of having a baby. That's what we're trying to prevent," said Allen, an assistant professor at the College of Medicine – Tucson. Allen is leading up what is called the PEACH Project.

The award recognizes extraordinary commitment to furthering the careers of Wildcats through mentoring, hiring or other career-related assistance.

Lynn B. Gerald, PhD., MSPH, Canyon Ranch endowed chair and professor in the Mel and Enid Zuckerman College of Public Health, has been appointed to the American Lung Association Leadership Board.

"The study is impressive in its scope, presenting comprehensive genomic profiling of the longitudinal samples from multiple patients," said Suwon Kim, PhD, an associate professor of basic medical sciences at the College of Medicine – Phoenix. "The results are significant, revealing the emergence of the alternate specific pathways in single tumor cells as they become resistant to CDK inhibitors and endocrine therapy. The study findings offer opportunities for evidence-guided therapeutic intervention for therapy-resistant breast cancer." Kim was not involved in the research.